期刊
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
卷 13, 期 2, 页码 325-341出版社
IJO PRESS
DOI: 10.18240/ijo.2020.02.18
关键词
retinoblastoma; biomarkers; epigenetics; proteomics; radiogenomics
资金
- National Natural Science Foundation of China [81672673]
- National Key Research and Development Program of China [2017YFA0104101]
Retinoblastoma (RB) is the most common intraocular malignancy of childhood caused by inactivation of the Rb genes. The prognosis of RB is better with an earlier diagnosis. Many diagnostic approaches and appropriate clinical treatments have been developed to improve clinical outcomes. However, limitations exist when utilizing current methods. Recently, many studies have identified identify new RB biomarkers which can be used in diagnosis, as prognostic indicators and may contribute to understanding the pathogenesis of RB and help determine specific treatment strategies. This review focuses on recent advances in the discovery of RB biomarkers and discusses their clinical utility and challenges from areas such as epigenetics, proteomics and radiogenomics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据